Azithronycine in management of brucellosis A clinical trial

64 cases clinically and serologically proved brucellosis [Br] in adult and pediatric age. 40 male and 24 female were given 2 courses each of six days 500 mg Azithromycine [Az] in a single morning dose one hour before breakfast with 5 days rest in between, children were given 8-10 mg/Kg body Wt. They were hospitalized maximally for 6 days and followed for six month. All cases were cured with no relapses [100% cure rate] with very minimal side effects. It is also cost effective